Bank of Nova Scotia Trust Co. Purchases Shares of 727 Thermo Fisher Scientific Inc. (NYSE:TMO)

Bank of Nova Scotia Trust Co. purchased a new stake in Thermo Fisher Scientific Inc. (NYSE:TMO) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 727 shares of the medical research company’s stock, valued at approximately $214,000.

A number of other hedge funds have also modified their holdings of TMO. FMR LLC boosted its position in Thermo Fisher Scientific by 33.5% in the 1st quarter. FMR LLC now owns 11,572,581 shares of the medical research company’s stock valued at $3,167,647,000 after buying an additional 2,900,868 shares during the period. BlackRock Inc. boosted its position in Thermo Fisher Scientific by 4.1% in the 1st quarter. BlackRock Inc. now owns 27,251,678 shares of the medical research company’s stock valued at $7,459,327,000 after buying an additional 1,074,400 shares during the period. Jennison Associates LLC boosted its position in Thermo Fisher Scientific by 2,589.9% in the 2nd quarter. Jennison Associates LLC now owns 819,138 shares of the medical research company’s stock valued at $240,564,000 after buying an additional 788,686 shares during the period. Marshall Wace LLP boosted its position in Thermo Fisher Scientific by 361.8% in the 1st quarter. Marshall Wace LLP now owns 775,103 shares of the medical research company’s stock valued at $212,161,000 after buying an additional 607,245 shares during the period. Finally, Janus Henderson Group PLC boosted its position in Thermo Fisher Scientific by 22.9% in the 2nd quarter. Janus Henderson Group PLC now owns 2,986,916 shares of the medical research company’s stock valued at $877,186,000 after buying an additional 555,802 shares during the period. 88.19% of the stock is owned by institutional investors.

In related news, Director Jim P. Manzi sold 1,833 shares of Thermo Fisher Scientific stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $272.93, for a total transaction of $500,280.69. Following the sale, the director now directly owns 28,592 shares in the company, valued at approximately $7,803,614.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Marc N. Casper sold 50,000 shares of Thermo Fisher Scientific stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $284.83, for a total transaction of $14,241,500.00. Following the sale, the chief executive officer now owns 342,193 shares in the company, valued at $97,466,832.19. The disclosure for this sale can be found here. 0.45% of the stock is owned by company insiders.

Thermo Fisher Scientific stock opened at $294.94 on Thursday. The stock has a market cap of $116.95 billion, a P/E ratio of 26.52, a price-to-earnings-growth ratio of 1.91 and a beta of 1.12. The company has a fifty day simple moving average of $280.90 and a 200-day simple moving average of $276.38. Thermo Fisher Scientific Inc. has a 12-month low of $208.34 and a 12-month high of $305.45. The company has a current ratio of 1.49, a quick ratio of 1.07 and a debt-to-equity ratio of 0.58.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, July 24th. The medical research company reported $3.04 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.01 by $0.03. Thermo Fisher Scientific had a net margin of 14.24% and a return on equity of 17.11%. The business had revenue of $6.32 billion during the quarter, compared to analysts’ expectations of $6.31 billion. During the same period in the previous year, the company earned $2.75 EPS. The company’s revenue for the quarter was up 3.9% on a year-over-year basis. As a group, sell-side analysts forecast that Thermo Fisher Scientific Inc. will post 12.24 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Tuesday, September 17th will be paid a dividend of $0.19 per share. The ex-dividend date is Monday, September 16th. This represents a $0.76 annualized dividend and a yield of 0.26%. Thermo Fisher Scientific’s dividend payout ratio is currently 6.83%.

Several equities analysts have commented on TMO shares. Wolfe Research started coverage on shares of Thermo Fisher Scientific in a research report on Thursday, May 30th. They issued an “outperform” rating for the company. Credit Suisse Group reaffirmed a “buy” rating and set a $310.00 price objective on shares of Thermo Fisher Scientific in a research report on Wednesday, July 31st. UBS Group lifted their price objective on shares of Thermo Fisher Scientific from $305.00 to $320.00 and gave the stock a “buy” rating in a research report on Thursday, May 23rd. Barclays set a $330.00 price objective on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Monday, July 15th. Finally, BTIG Research lifted their price objective on shares of Thermo Fisher Scientific to $320.00 and gave the stock a “buy” rating in a research report on Thursday, May 23rd. Two research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Thermo Fisher Scientific currently has a consensus rating of “Buy” and a consensus price target of $303.17.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

See Also: Options Trading – Understanding Strike Price

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.